Poging GOUD - Vrij

Intas Pharmaceuticals collaborates with IntegriMedical

Bio Spectrum

|

February 2026

Ahmedabad-based Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India's first NeedleFree Injection System (N-FIS), to introduce this revolutionary technology for use in IVF and gynaecology treatments across India. This marks a significant milestone in IVF and women's health.

Intas Pharmaceuticals collaborates with IntegriMedical

Securing exclusivity for a first-of-its-kind needle-free injector transforms both the delivery and experience of treatment, placing patient comfort and confidence at the forefront of care. Through this agreement, Intas became the first and only company in I

MEER VERHALEN VAN Bio Spectrum

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Bio Spectrum

Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr

Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.

time to read

1 min

February 2026

Bio Spectrum

146 Biosimilars in 25 Years: India at Global Scale

Biosimilars are an important part of modern therapeutics and a central component of India's shift beyond a generics-led pharmaceutical model.

time to read

8 mins

February 2026

Bio Spectrum

Decode Age raises Rs 14.48 Cr to advance longevity science and gut microbiome research

Bengaluru-based Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs 14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Havih Envirosciences announces partnership with Andhra Pradesh

Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC

Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

IIT-D and AIIMS develop swallowable microdevice for microbiome study

Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Care ADHD expands global operations with first GCC in India

Care ADHD, one of the United Kingdom's fastest growing digital mental health companies and a key partner to the NHS, has announced the opening of its first Global Capability Centre (GCC) in India - Bengaluru.

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size